Peripheral T-cell lymphoma · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
TFC, then allo HSCT Variant #01 Partial | — | R 6 200 | — | — | — | — | — | — |
BEAM Variant #01 Partial | — | R 4 294 | — | — | — | — | — | — |
Cyclophosphamide and TBI Variant #01 | — | R 1 176 | — | — | ~90.0 mo | — | — | 2 |
Radiation therapy N/A - radiation Partial | — | — | 49d | ~25.5 mo | ~10.6 mo | ~16 | — | 24 |
4 of 4 regimens shown